Why This Regeneron Eye Rival Just Catapulted More Than 120%

Kodiak Sciences stock skyrocketed Monday on a double win for its potential rivals to Regeneron Pharmaceuticals' blockbuster eye drug, Eylea. The post Why This Regeneron Eye Rival Just Catapulted More Than 120% appeared first on Investor's Business Daily.